CoChat

Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic Evaluation

van den Belt, Angelique, Prins, Martin, Gallus, Alexander, Büller, Harry, Bossuyt, Patrick, for the TASMAN Study Group · 1998 · Thrombosis and Haemostasis

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Summary: Two clinical trials in patients with acute deep venous thrombosis have indicated that the outpatient management with fixed-dose, subcutaneous low-molecular-weight heparin is at least as effective and safe as inpatient treatment with unfractionated intravenous heparin with respect to recurrent venous thromboembolism and major bleeding. We performed an economic evaluation alongside one of these trials to assess the cost consequences of the outpatient management strategy. Data were collected through case record forms, complemented by a prospective questionnaire in 78 consecutive patients, interviews with health care providers, and hospital data bases. Our study demonstrated that seventy-five percent of patients allocated to low-molecular-weight heparin received treatment either entirely at home or after a brief hospital stay. Fifteen percent of these patients required professional domiciliary care. Within-centre comparisons of resource utilisation in terms of natural units showed that outpatient management with low-molecular-weight heparin reduced the average number of hospital days in the initial treatment period in nine centres by 59 percent (95% CI: 43 to 71 percent) accompanied by a limited increase in outpatient and professional domiciliary care. The average reduction in hospital days at the end of follow up was 40 percent (95% CI: 25 to 54 percent). A cost-minimisation analysis, focusing on resource utilisation directly related to the treatment of deep venous thrombosis and associated costs in one centre demonstrated a cost reduction of 64 percent (95% CI: 56 to 72 percent) with the outpatient management with low-molecular-weight heparin. These data suggest that outpatient management of patients with proximal venous thrombosis using low-molecular-weight heparin reduces resource utilisation and total treatment cost. Implementation should be preceded by a cautious evaluation of a potential cost shifting and organisational prerequisites.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-0037-1614975

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 13 references

Cited by

See all 97

Metadata

Authors
van den Belt, A., Prins, M., Gallus, A., Büller, H., Bossuyt, P., & for the TASMAN Study Group
Affiliations
  • University of Amsterdam (NL)
  • Flinders Medical Centre (AU)
Venue
Thrombosis and Haemostasis
Published
1998
Volume
79
Issue
02
Pages
259-263
ISSN
  • 0340-6245 (ISSN-L)
  • 2567-689X
OpenAlex
W1782024978
Cited by
90
References
13
Citations by year
2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 4 · 2013: 1 · 2012: 2
FWCI
10.80
Type
journal article
Language
en
Open access
closed
Locations
  • Thrombosis and Haemostasis (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Funders
Sanofi Winthrop
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords
deep vein thrombosis, outpatient management, low molecular weight heparin, subcutaneous anticoagulation, inpatient care, length of hospital stay, resource utilization (health care), treatment costs, cost minimization, venous thromboembolism, home care, cost shifting
MeSH terms
Administration, Cutaneous, Ambulatory Care, Anticoagulants, Clinical Trials as Topic, Costs and Cost Analysis, Evaluation Studies as Topic, Heparin, Heparin, Low-Molecular-Weight, Humans, Infusions, Intravenous, Thrombophlebitis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic Evaluation. https://app.cochat.ai/papers/10.1055/s-0037-1614975
The paper
van den Belt, A., Prins, M., Gallus, A., Büller, H., Bossuyt, P., & for the TASMAN Study Group. (1998). Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic Evaluation. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0037-1614975

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.